Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----[1] 309 💬
2(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----[1] 309 💬
3Brivaracetam[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[2] 149, 309 💬
4Brivaracetam 25 mg[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[1] 309 💬
5Brivaracetam 50 mg[1] Brivaracetam[1] Brivaracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[1] 309 💬
6BRV 2.5 mg----[1] 309 💬
7BRV 25 mg----[1] 309 💬
8BRV 50 mg----[1] 309 💬
9Intravenous Immunoglobulin----[7] 13, 14, 35, 38, 39, 51, 309 💬
10REQUIP[1] Ropinirole[1] Ropinirole 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309 💬
11ROPINIROLE[1] Ropinirole[1] Ropinirole 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 74, 309 💬
12Ropinirole Hydrochloride[1] Ropinirole[1] Ropinirole 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309 💬
13Ucb 34714----[2] 149, 309 💬